Literature DB >> 7582485

Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.

A Rubino1, V Ralevic, G Burnstock.   

Abstract

1. The direct vascular effects of adenosine and ATP were compared in the isolated and perfused mesenteric arterial bed of the rat. The actions of analogues of adenosine and ATP were also examined. 2. In preparations at basal tone, adenosine lacked vasoconstrictor actions, while ATP elicited dose-dependent vasoconstrictor responses. When the tone of preparations was raised by adding methoxamine to the perfusate, adenosine and its stable analogue, 2-chloroadenosine (2-CADO) elicited dose-dependent vasodilation. The A2 adenosine receptor agonist, 5'-N-ethylcarboxamidoadenosine (NECA) was active at lower doses than adenosine, while the A2a-selective agonist, CGS 21680 and the selective A1 agonist, N6-cyclopentyladenosine (CPA) failed to induce vasodilatation. ATP and its analogue, 2-methylthio ATP, elicited dose-dependent vasodilatation at doses 400 fold lower than adenosine. 3. Vasodilator responses to adenosine and 2-CADO were sensitive to antagonism by 1 microM 8-sulphophenyltheophylline (8-SPT) and were unaffected by inhibition of nitric oxide synthase by N omega-nitro-L-arginine methyl ester (L-NAME). In contrast, vasodilator responses to ATP were not sensitive to antagonism by 8-SPT and were almost abolished by L-NAME treatment. 4. These results indicate that in the rat mesenteric arterial bed, while both adenosine and ATP participate in the purinergic control of vascular tone, adenosine appears to be a weaker vasodilator than ATP and lacks vasoconstrictor action. A2b adenosine receptors account for the adenosine-induced vasodilatation which is independent of the production of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582485      PMCID: PMC1908478          DOI: 10.1111/j.1476-5381.1995.tb14981.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats.

Authors:  E K Jackson
Journal:  Am J Physiol       Date:  1987-10

2.  Vasodilator response of coronary smooth muscle to the sympathetic co-transmitters noradrenaline and adenosine 5'-triphosphate.

Authors:  L Corr; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 3.  Purinoceptors: are there families of P2X and P2Y purinoceptors?

Authors:  M P Abbracchio; G Burnstock
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

Review 4.  Adenosine receptor subtypes.

Authors:  M G Collis; S M Hourani
Journal:  Trends Pharmacol Sci       Date:  1993-10       Impact factor: 14.819

Review 5.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1994-08       Impact factor: 14.819

Review 6.  The role of endothelium in the responses of vascular smooth muscle to drugs.

Authors:  R F Furchgott
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

Review 7.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

8.  Comparative effects of a selective adenosine A2 receptor agonist, CGS 21680, and nitroprusside in vascular smooth muscle.

Authors:  J L Balwierczak; R Sharif; C M Krulan; F P Field; G B Weiss; M J Miller
Journal:  Eur J Pharmacol       Date:  1991-04-17       Impact factor: 4.432

9.  A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Modulation of the vasoconstrictor response to adrenergic stimulation by nucleosides and nucleotides.

Authors:  P Lukacsko; A Blumberg
Journal:  J Pharmacol Exp Ther       Date:  1982-08       Impact factor: 4.030

View more
  21 in total

1.  Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Preconditioning protects against ischemia/reperfusion injury of the liver.

Authors:  B Nilsson; S Friman; B I Gustafsson; D S Delbro
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 3.  The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases.

Authors:  Anna Eisenstein; Shenia Patterson; Katya Ravid
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

4.  Effects of NAD at purine receptors in isolated blood vessels.

Authors:  E Alefishat; S P H Alexander; V Ralevic
Journal:  Purinergic Signal       Date:  2014-10-15       Impact factor: 3.765

5.  Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed.

Authors:  V Ralevic; J Jankowski; H Schlüter
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

6.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

7.  A2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin.

Authors:  Xiulan Yang; Wenkuan Xin; Xi-Ming Yang; Atsushi Kuno; Thomas C Rich; Michael V Cohen; James M Downey
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.

Authors:  Shraddha Nayak; Md Abdul H Khan; Tina C Wan; Hong Pei; Joel Linden; Melinda R Dwinell; Aron M Geurts; John D Imig; John A Auchampach
Journal:  Purinergic Signal       Date:  2015-09-18       Impact factor: 3.765

9.  Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.

Authors:  P Nieri; E Martinotti; V Calderone; M C Breschi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.

Authors:  Bunyen Teng; Daniel Fil; Stephen L Tilley; Catherine Ledent; Thomas Krahn; S Jamal Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.